secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prelude Therapeutics Inc (PRLD)
CIK:        0001678660
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0000950170-24-072249
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prelude Therapeutics posts corporate presentation and SMARCA degrader educational series
--------------------------------------------------------------------------------

- Company furnished a corporate presentation (Exhibit 99.1) dated June 2024.
- Launched educational video series on SMARCA degraders available via investor website.
- No financial results, clinical data, or material business changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1678660/000095017024072249/0000950170-24-072249-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1678660/000095017024072249/prld-20240612.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-072249

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer